Transoral incisionless fundoplication with EsophyX for gastroesophageal reflux disease: clinical efficacy is maintained up to 10 years

Abstract

Background Transoral incisionless fundoplication with EsophyX is reported to be effective in patients with gastroesophageal reflux disease in short-medium term follow-up.

Aim To examine clinical outcomes up to 10 years.

Methods In total, 51 procedures were performed in 50 patients. All entered a yearly clinical follow-up schedule including gastroesophageal reflux disease health-related quality-of-life questionnaires, heartburn and regurgitation scores, and daily proton pump inhibitor consumption.

Results The procedure was successfully performed in 49/50 patients. Severe complications occurred in 2/51 procedures. The remaining 49 patients were re-evaluated at 2 and 3 years, 41 after 5 years, 30 after 7 years, and 14 after 10 years. Eight patients were lost to follow-up between 3 and 5 years. Seven patients who were unresponsive to endoscopic fundoplication underwent surgical fundoplication. The mean scores at 2 years were significantly lower than before the procedure and did not change substantially during the follow-up. The rates of patients who had stopped or halved antisecretive therapy 2, 3, 5, 7, and 10 years after the procedure were 86.7 %, 84.4 %, 73.5 %, 83.3 %, and 91.7 %, respectively.

Conclusions Transoral incisionless fundoplication with EsophyX is an effective therapeutic option for symptomatic gastroesophageal reflux disease patients, with Hill grades I – II or hiatal hernia < 2 cm, who refuse life-long medical therapy or surgery.

• References

• 1 Cadière GB, Rajan A, Rquibate M. et al. Endoluminal fundoplication (ELF) – evolution of EsophyX™, a new surgical device for transoral surgery. Minim Invasive Ther Allied Technol 2006; 15: 348-355
• 2 Cadiere GB, Rajan A, Germay O. et al. Endoluminal fundoplication by a transoral device for the treatment of GERD: a feasibility study. Surg Endosc 2008; 22: 333-342
• 3 Jobe BA, O’Rourke RW, McMahon BP. et al. Transoral endoscopic fundoplication in the treatment of gastroesophageal reflux disease. The anatomic and physiologic basis for reconstruction of the esophago-gastric junction using a novel device. Ann Surg 2008; 248: 69-76
• 4 Bell RC, Cadière GB. Transoral rotational esophagogastric fundoplication: technical, anatomical, and safety considerations. Surg Endosc 2011; 25: 2387-2399
• 5 Spechler SJ. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. NEJM 1992; 326: 786-792
• 6 Herron DM, Swanstroem LL, Ramzi N. et al. Factors predictive of dysphagia after laparoscopic Nissen fundoplication. Surg Endosc 1999; 13: 1180-1183
• 7 Catarci M, Gentileschi P, Papi C. et al. Evidence-based appraisal of antireflux fundoplication. Ann Surg 2004; 239: 325-337
• 8 Huang X, Chen S, Zhao H. et al. Efficacy of transoral incisionless fundoplication (TIF) for the treatment of GERD: a systematic review with meta-analysis. Surg Endosc 2017; 31: 1032-1044
• 9 Witteman BPL, Strijkers R, de Vries E. et al. Transoral incisionless fundoplication for treatment of gastro-esophageal reflux disease in clinical practice. Surg Endosc 2012; 26: 3307-3315
• 10 Muls V, Eckardt AJ, Marchese M. et al. Three-year results of a multicenter prospective study of transoral incisionless fundoplication. Surg Innov 2013; 20: 321-330
• 11 Testoni PA, Testoni S, Mazzoleni G. et al. Long-term efficacy of transoral incisionless fundoplication with EsophyX (TIF 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study. Surg Endosc 2015; 29: 2770-2780
• 12 Trad K, Fox MA, Simoni G. et al. Transoral fundoplication offers durable symptom control for chronic GERD: 3-year report from the TEMPO randomized trial with a crossover arm. Surg Endosc 2017; 31: 2498-2508
• 13 Stefanidis G, Viazis N, Kotsikoros N. et al. Long-term benefit of transoral incisionless fundoplication using the Esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy. Dis Esophagus 2017; 30: 1-8
• 14 Trad KS, Barnes WE, Prevou ER. et al. The TEMPO trial at 5 years: transoral fundoplication (TIF 2.0) is safe, durable, and cost-effective. Surg Innov 2018; 25: 149-157
• 15 Richter J, Kumar A, Lipka S. et al. Efficacy of laparoscopic Nissen fundoplication vs transoral incisionless fundoplication or proton pump inhibitors in patients with gastro-esophageal reflux disease: a systematic review and network meta-analysis. Gastroenterology 2018; 154: 1298-1308.e7
• 16 Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006; 130: 1377-1390
• 17 Velanovich V, Vallance SR, Gusz JR. et al. Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg 1996; 183: 217-224
• 18 Raymond JM, Marquis P, Bechade D. et al. Assessment of quality of life of patients with gastroesophageal reflux. Elaboration and validation of a specific questionnaire. Gastroenterol Clin Biol 1999; 23: 32-39
• 19 Lundell LR, Dent J, Bennett JR. et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles Classification. Gut 1999; 45: 172-180
• 20 Haack HG, Hansen RD, Malcolm A. et al. Ineffective esophageal motility: manometric subsets exhibit different symptom profiles. World J Gastroenterol 2008; 14: 3719-3724
• 21 Bell RC, Mavrelis PG, Barnes WE. et al. A prospective multicenter registry of patients with chronic gastro-esophageal reflux disease receiving transoral incisionless fundoplication. J Am Coll Surg 2012; 215: 794-809
• 22 Bell RCW, Fox MA, Barnes WE. et al. Univariate and multivariate analyses of preoperative factors influencing symptomatic outcomes of transoral fundoplication. Surg Endosc 2014; 28: 2949-2958
• 23 Broeders JAJL, Mauritz FA, Ahmed Alì U. et al. Systematic review and meta-analysis of laparoscopic Nissen (posterior total) versus Toupet (posterior partial) fundoplication for gastro-esophageal reflux disease. Br J Surg 2010; 97: 1318-1330
• 24 Garg SK, Gurusamy KS. Laparoscopic fundoplication surgery versus medical management for gastro-oesophageal reflux disease (GORD) in adults. Cochrane Database Syst Rev 2015; 11: 1-35
• 25 Loedrup A, Pottegard A, Hallas J. et al. Use of proton pump inhibitors after antireflux surgery. A nationwide register-based follow-up study. Gut 2014; 63: 1544-1549
• 26 Lundell L, Bell M, Ruth M. Systematic review: laparoscopic fundoplication for gastro-esophageal reflux disease in partial responders to proton pump inhibitors. World J Gastroenterol 2014; 20: 804-813
• 27 Kelly JJ, Watson DI, Chin KF. et al. Laparoscopic Nissen fundoplication: clinical outcomes at 10 years. J Am Coll Surg 2007; 205: 570-575